We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+1.24%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.1B
AUM Growth
+$312M
Cap. Flow
-$44.8M
Cap. Flow %
-0.37%
Top 10 Hldgs %
38.76%
Holding
1,279
New
83
Increased
328
Reduced
404
Closed
81

Sector Composition

Rank Sector Weight
1 Real Estate 72.69%
2 Technology 4.79%
3 Financials 3.72%
4 Healthcare 2.91%
5 Industrials 2.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBPO
976
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$25K ﹤0.01%
217
-27
-11% -$3.13K
BBIO icon
977
BridgeBio Pharma
BBIO
$16.5B
$24K ﹤0.01%
+697
New +$19.3K
EWW icon
978
iShares MSCI Mexico ETF
EWW
$1.91B
$23K ﹤0.01%
500
ICPT
979
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$23K ﹤0.01%
185
-20
-10% -$1.79K
IMMU
980
DELISTED
Immunomedics Inc
IMMU
$23K ﹤0.01%
1,091
-123
-10% -$2.17K
BPMC
981
DELISTED
Blueprint Medicines
BPMC
$22K ﹤0.01%
278
-35
-11% -$2.62K
BRT
982
BRT Apartments
BRT
$283M
$22K ﹤0.01%
1,300
UTHR icon
983
United Therapeutics
UTHR
$26.3B
$22K ﹤0.01%
248
-30
-11% -$2.64K
ADPT icon
984
Adaptive Biotechnologies
ADPT
$3.61B
$21K ﹤0.01%
+702
New +$20.2K
AZUL
985
DELISTED
Azul
AZUL
$21K ﹤0.01%
500
-175
-26% -$6.74K
KYNB
986
Kyntra Bio
KYNB
$28.5M
$21K ﹤0.01%
20
-2
-9% -$2.04K
NKTR icon
987
Nektar Therapeutics
NKTR
$2.41B
$21K ﹤0.01%
66
-455
-87% -$132K
TDOC icon
988
Teladoc Health
TDOC
$1.61B
$21K ﹤0.01%
250
ARGX icon
989
argenx
ARGX
$55.6B
$20K ﹤0.01%
122
-14
-10% -$1.89K
AXSM icon
990
Axsome Therapeutics
AXSM
$12.3B
$20K ﹤0.01%
+195
New +$7.88K
FPI
991
Farmland Partners
FPI
$420M
$20K ﹤0.01%
3,000
IOVA icon
992
Iovance Biotherapeutics
IOVA
$2.19B
$20K ﹤0.01%
712
-73
-9% -$1.66K
CRSP icon
993
CRISPR Therapeutics
CRSP
$4.6B
$19K ﹤0.01%
336
-12
-3% -$655
MYOK
994
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$19K ﹤0.01%
261
-29
-10% -$1.76K
AGIO icon
995
Agios Pharmaceuticals
AGIO
$2.2B
$18K ﹤0.01%
386
+15
+4% +$567
ALLO icon
996
Allogene Therapeutics
ALLO
$604M
$18K ﹤0.01%
+688
New +$18.9K
DCPH
997
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$18K ﹤0.01%
288
-24
-8% -$1.14K
ALK icon
998
Alaska Air
ALK
$5.3B
$17K ﹤0.01%
248
-700
-74% -$47.8K
ALKS icon
999
Alkermes
ALKS
$8.79B
$17K ﹤0.01%
889
-5,153
-85% -$102K
GRFS
1000
Grifois
GRFS
$5.27B
$17K ﹤0.01%
711
-94
-12% -$2.05K

Similar funds

Daiwa Securities Group's Q4 2019 Portfolio in Review

As of Q4 2019, Daiwa Securities Group held 1,279 positions worth $12.1B, up 2.6% from $11.8B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Daiwa Securities Group's Q4 2019 filing shows 83 new, 328 increased, 404 reduced and 81 closed positions. Its largest new stake was Performance Food Group: 109,263 shares worth $5.63M. The largest sale was Sun Communities, an estimated $208M.

By sector, the portfolio is most concentrated in Real Estate at 73% of assets, down from 73% a quarter earlier, followed by Technology and Financials.

  • Daiwa Securities Group's largest Q4 2019 buy was Performance Food Group: 109,263 shares worth $5.63M.
  • Daiwa Securities Group added most to Digital Realty Trust in Q4 2019, an estimated $239M increase.
  • Daiwa Securities Group's biggest Q4 2019 reduction was Sun Communities, cutting an estimated $208M.
  • Daiwa Securities Group fully exited State Street SPDR S&P 500 ETF Trust in Q4 2019, selling an estimated $13.1M.
  • Daiwa Securities Group's ten largest holdings make up 39% of its $12.1B portfolio in Q4 2019.
  • Daiwa Securities Group opened 83 new positions and closed 81 in Q4 2019.
  • Daiwa Securities Group's portfolio value rose 2.6% quarter-over-quarter to $12.1B.

Based on Daiwa Securities Group's 13F filing for Q4 2019, filed 31 Jan 2020.